SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?


To: E who wrote (1026)6/3/1998 8:18:00 PM
From: HeyRainier  Read Replies (2) | Respond to of 4140
 
E, you put me in a tough position. My training has taught me to avoid stocks that are exhibiting weakness, for weakness can often breed weakness. My previous views were only made for the shorter term characteristics of the issue, and hence are intended only as a short term navigation tool.

While the short term is slightly weak, the intermediate term characteristics of SNRS are by many means bullish. That bullishness, however, seems to have deteriorated somewhat, and traders are getting cautious enough such that they are taking profits upon any sign of near term upside strength.

I do not blame them.

Key intermediate term momentum indicators have peaked as of the past two trading days; the main upward trend has been violated, and the recent show of strength to $8.50 was quickly snuffed out, bringing us again to the 50 day moving average. The price formation is that of a Descending Triangle, with the expected opposite characteristics of the Bullish Ascending Triangle that I often refer to on other threads. If the stock does not immediately show upward strength in the near term, I think $7.50 will not be beyond the realm of possibility.

But I still have not answered your question.

Intermediate term, this issue looks bullish, though to a decreasing extent as days pass. The short term, however, continues to be bearish. If I were to look to acquire, I would do it on the way up, after the short term bearishness has been sufficiently negated, and the intermediate term uptrend has been reconfirmed. This ensures a minimum of portfolio drawdown. While always keeping in mind that our goal is to maximize profits, it is often forgotten that we should also always seek to minimize loss. We achieve both by subscribing to the above technique.

Trade with the trend, because the trend is your friend.

Regards,

Rainier



To: E who wrote (1026)6/3/1998 8:21:00 PM
From: Sylvester  Read Replies (2) | Respond to of 4140
 
Not much to feel good about today. Here's a post from Yahoo that I thought you might enjoy for what it's worth.

Follow up on SZASZ 52 (Post 705) tomoosker
Jun 3 1998
5:31PM EDT
Good post, rational and reasonable. In relationship to Mutual Funds able to buy SNRS once it hits the NASDAQ I have some encouraging info from a very good source. A certain opthalmologist involved in SNRS and heavily invested in same, recently had a get together at his home in Boca Raton, Fla, with some of the key people people from the Templeton Mutual Funds. According to my source they are ready to buy when it hits the NASDAQ. This is more than a rumor. Same opthalmologist thinks it may hit 12 just from the NASDAQ listing.

Hope he is right.

Tomoosker

I defer to Rainer's TA in the short term. Momentum is gone, not only from SNRS but from the market as a whole. I wouldn't buy yet as we made see a 15% downslide. At some point, you need to hold your position, keep cash and buy on the way up. Not as profitable but more reasonable.

My question is, Rainer, does your TA take into consideration the NASDAQ listing?